Novo Nordisk A/S ADR (NVO)
72.65 x 4 72.70 x 12
Pre-market by (Cboe BZX)
73.60 -1.73 (-2.30%) 03/25/25 [NYSE]
72.65 x 4 72.70 x 12
Pre-market 72.66 -0.94 (-1.28%) 06:51 ET
for Tue, Mar 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 12,261,320 | 10,511,240 | 9,821,058 | 9,514,814 | 9,526,155 |
| Cost of Goods | 1,862,583 | 1,666,799 | 1,482,538 | 1,443,770 | 1,448,192 |
| Gross Profit | 10,398,740 | 8,844,442 | 8,338,520 | 8,071,045 | 8,077,962 |
| Operating Expenses | 5,154,582 | 3,859,878 | 4,596,782 | 3,435,037 | 4,207,256 |
| Operating Income | 5,244,737 | 4,985,363 | 3,742,276 | 4,636,778 | 3,870,901 |
| Interest Expense | 416,784 | 121,015 | 225,397 | 301,974 | -260,988 |
| Other Income | 243,872 | 203,854 | 138,529 | 312,457 | -138,534 |
| Pre-tax Income | 5,071,825 | 5,068,202 | 3,655,408 | 4,647,261 | 3,993,355 |
| Income Tax | 1,045,207 | 1,044,034 | 762,193 | 948,002 | 818,001 |
| Net Income Continuous | 4,026,618 | 4,024,167 | 2,893,215 | 3,699,259 | 3,175,355 |
| Net Income | $4,026,618 | $4,024,167 | $2,893,215 | $3,699,259 | $3,175,355 |
| EPS Basic Total Ops | 0.90 | 0.90 | 0.65 | 0.83 | 0.71 |
| EPS Basic Continuous Ops | 0.91 | 0.90 | 0.65 | 0.83 | 0.71 |
| EPS Diluted Total Ops | 0.90 | 0.90 | 0.65 | 0.83 | 0.71 |
| EPS Diluted Continuous Ops | 0.90 | 0.90 | 0.65 | 0.83 | 0.71 |
| EPS Diluted Before Non-Recurring Items | 0.91 | 0.90 | 0.65 | 0.83 | 0.71 |
| EBITDA(a) | $5,965,065 | $5,338,726 | $5,014,821 | $5,061,056 | $4,300,201 |